AVEO Oncology (AVEO) Tops Q4 EPS by 8c

AVEO Oncology (NASDAQ: AVEO) reported Q4 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $17.93 million.

For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Spirit Blockchain Capital reports AGM results and board changes
• DB cautious on cruise stocks as fundamentals “not as clear as bulls believe”